Remote pharmaceutical care for patients with rheumatoid arthritis and psoriasis

Martínez-Santana, Virginia; Boix-Montañés, Antoni; Fernández-Cañabate, Eva; González-Melarde, B.; Miserachs-Aranda, Núria; Modamio-Charles, Pilar; Fernández-Lastra, C.; Mariño-Hernández, E L

doi:10.1007/s11096-020-01200-3

Cited by 5 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies suggest that pharmacist services improve patient satisfaction and medication compliance with disease‐modifying antirheumatic drugs (Martinez‐Santana et al., 2021; Park et al., 2022; Peter et al., 2021). Furthermore, recent research, including studies by Jones and Trickey (2022) and Ruiz‐Ramos et al.…”

Section: Introductionmentioning

confidence: 99%

The value of having multidisciplinary input in early arthritis clinics

Petford,

Jiao,

Sandhu

2024

Musculoskeletal Care

View full text Add to dashboard Cite

patient experiences 1 | BACKGROUND Rheumatoid arthritis (RA) is a chronic condition requiring lifelong management. It presents significant challenges due to the complexities of medication management and comorbid conditions, which require careful monitoring of medication safety and effectiveness. These challenges frequently affect patient adherence to prescribed treatments (Park et al., 2022). Lavielle et al. (2018) conducted a systematic literature review that highlights the critical link between medication non-adherence and poorer health outcomes among RA patients. This review emphasises the importance of educational interventions, delivered by a range of healthcare professionals, including physicians, pharmacists, and nurses, in improving medication adherence.

show abstract

Section: Introductionmentioning

confidence: 99%

The value of having multidisciplinary input in early arthritis clinics

Petford,

Jiao,

Sandhu

2024

Musculoskeletal Care

View full text Add to dashboard Cite

show abstract

“…Several studies have been conducted to evaluate the effectiveness of pharmacist services on the improvement of satisfaction and medication compliance in European patients with RA. 7 8 Mary et al 8 demonstrated that a continuous pharmacist service sending mobile phone text messages every week for 6 months had a positive effect on the improvement of treatment adherence compared with pharmacist-led medication counselling in patients taking methotrexate for RA. However, there have been few randomised controlled trials to assess the impact of systematic pharmaceutical care services on quality of life, and clinical outcomes prospectively considering the characteristics of patients with RA.…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Impact of a pharmaceutical care service for patients with rheumatoid arthritis using a customised mobile device (the PROUD trial): study protocol for a randomised controlled trial

et al. 2022

View full text Add to dashboard Cite

IntroductionRheumatoid arthritis (RA) generally requires lifelong treatment; however, its medication complexity might affect non-adherence. Pharmacist-led telehealth services were as effective as face-to-face services and reduced potential side effects in outpatients with chronic diseases. This study aims to analyse the effect of a telepharmacy service with a customised mobile device in comparison with the usual pharmacist service on the humanistic and clinical outcomes in patients with RA.Methods and analysisThe study is designed as a prospective, randomised, open-label, and controlled trial to compare the humanistic and clinical outcomes of the pharmaceutical care service with monthly telecommunications and a customised mobile application (telepharmacy care group) against the usual service by community pharmacists (usual care group) in 256 patients with RA and prescribed at least one of the disease-modifying antirheumatic drugs. Participants will be recruited from a tertiary hospital in Republic of Korea with written informed consent. The primary outcome will be the changes in health-related quality of life as measured by the Korean version of the EuroQoL’s five-dimensional questionnaire at 6 months compared with baseline. The secondary outcomes will be the changes in the following: scores of the Korean version of the Compliance Questionnaire-Rheumatology and medication knowledge at 3 and 6 months compared with baseline; scores of the Korean version of the Pharmacy Service Questionnaire at 6 months compared with baseline; clinical parameters such as erythrocyte sedimentation rate, C reactive protein level, and pain score at 3 and 6 months compared with baseline; frequency of acute care utilisation over 6 months. Analysis will be carried out with intent-to-treat and per-protocol principles.Ethics and disseminationThe study protocol was reviewed and approved by the Institutional Review Board (IRB) of Daegu Catholic University Medical Center (IRB no. CR-21-082-L, 14 July 2021). The study findings will be published in peer-reviewed journals.Trial registration numberKCT0006508.

show abstract